您的位置: 首页 > 农业专利 > 详情页

COMBINATIONS OF ANTI-HER2-ANTIBODY-MEDICINE AND CHEMOTHERAPEUTIC COMPOUNDS AND METHODS OF APPLICATION
专利权人:
ДЖЕНЕНТЕК; ИНК. (US)
发明人:
БЕРРИ Лини (US),ФИЛЛИПС Гейл Льюис (US),СЛИВКОВСКИ Марк Кс. (US)
申请号:
RU2010142390/15
公开号:
RU2010142390A
申请日:
2009.03.10
申请国别(地区):
RU
年份:
2012
代理人:
摘要:
1. A method of treating a hyperproliferative disorder, comprising administering a therapeutic combination in the form of a combination composition, or alternately to a mammal, in which the therapeutic combination comprises a therapeutically effective amount of trastuzumab-MCC-DM1 and a therapeutically effective amount of a chemotherapeutic agent selected from an HER2 dimerization inhibitor antibody, an anti-VEGF antibody , 5-FU, carboplatin, lapatinib, ABT-869, docetaxel, GDC-0941 and GNE-390. ! 2. The method of claim 1, wherein the HER2 dimerization inhibitor antibody is Pertuzumab. ! 3. The method of claim 1, wherein the anti-VEGF antibody is bevacizumab. ! 4. The method according to claim 1, wherein the chemotherapeutic agent is 5-FU. ! 5. The method according to claim 1, in which the chemotherapeutic agent is carboplatin. ! 6. The method according to claim 1, in which the chemotherapeutic agent is lapatinib. ! 7. The method according to claim 1, in which the chemotherapeutic agent is ABT-869. ! 8. The method according to claim 1, in which the chemotherapeutic agent is docetaxel. ! 9. The method according to claim 1, in which the chemotherapeutic agent is GDC-0941. ! 10. The method according to claim 1, in which the chemotherapeutic agent is GNE-390. ! 11. The method according to claim 1, wherein a therapeutically effective amount of trastuzumab-MCC-DM1 and a therapeutically effective amount of a chemotherapeutic agent are administered as a combined composition. ! 12. The method according to claim 1, in which a therapeutically effective amount of trastuzumab-MCC-DM1 and a therapeutically effective amount of a chemotherapeutic agent are administered alternately. ! 13. The method according to item 12, in which the mammal is administered a chemotherapeutic agent and then subsequently1. Способ лечения гиперпролиферативного нарушения, включающий введение терапевтической комбинации в виде комбинированной композиции или поочередно млекопитающему, в котором терапевтическ
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充